Emerging therapies for Parkinson's disease.
Identifieur interne : 000372 ( Ncbi/Checkpoint ); précédent : 000371; suivant : 000373Emerging therapies for Parkinson's disease.
Auteurs : Werner Poewe [Autriche] ; Philipp Mahlknecht ; Joseph Jankovic [États-Unis]Source :
- Current opinion in neurology ; 2012.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Antiparkinson Agents.
- chemical , classification : Antiparkinson Agents.
- therapy : Parkinson Disease.
- Clinical Trials as Topic, Drug Administration Routes, Drug Delivery Systems, Humans.
Abstract
The experimental therapeutics of Parkinson's disease are reviewed, highlighting the current pipeline of emerging therapeutic approaches.
DOI: 10.1097/WCO.0b013e3283542fde
PubMed: 22772874
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000053
- to stream PubMed, to step Curation: 000053
- to stream PubMed, to step Checkpoint: 000061
- to stream Ncbi, to step Merge: 000372
- to stream Ncbi, to step Curation: 000372
Links to Exploration step
pubmed:22772874Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Emerging therapies for Parkinson's disease.</title><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="1"><nlm:affiliation>University-Klinik für Neurologie, University of Innsbruck, Innsbruck, Austria. werner.poewe@i-med.ac.at</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>University-Klinik für Neurologie, University of Innsbruck, Innsbruck</wicri:regionArea><wicri:noRegion>Innsbruck</wicri:noRegion></affiliation></author><author><name sortKey="Mahlknecht, Philipp" sort="Mahlknecht, Philipp" uniqKey="Mahlknecht P" first="Philipp" last="Mahlknecht">Philipp Mahlknecht</name></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="doi">10.1097/WCO.0b013e3283542fde</idno><idno type="RBID">pubmed:22772874</idno><idno type="pmid">22772874</idno><idno type="wicri:Area/PubMed/Corpus">000053</idno><idno type="wicri:Area/PubMed/Curation">000053</idno><idno type="wicri:Area/PubMed/Checkpoint">000061</idno><idno type="wicri:Area/Ncbi/Merge">000372</idno><idno type="wicri:Area/Ncbi/Curation">000372</idno><idno type="wicri:Area/Ncbi/Checkpoint">000372</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Emerging therapies for Parkinson's disease.</title><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="1"><nlm:affiliation>University-Klinik für Neurologie, University of Innsbruck, Innsbruck, Austria. werner.poewe@i-med.ac.at</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>University-Klinik für Neurologie, University of Innsbruck, Innsbruck</wicri:regionArea><wicri:noRegion>Innsbruck</wicri:noRegion></affiliation></author><author><name sortKey="Mahlknecht, Philipp" sort="Mahlknecht, Philipp" uniqKey="Mahlknecht P" first="Philipp" last="Mahlknecht">Philipp Mahlknecht</name></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></analytic><series><title level="j">Current opinion in neurology</title><idno type="e-ISSN">1473-6551</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (classification)</term><term>Clinical Trials as Topic</term><term>Drug Administration Routes</term><term>Drug Delivery Systems</term><term>Humans</term><term>Parkinson Disease (therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="classification" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term><term>Drug Administration Routes</term><term>Drug Delivery Systems</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The experimental therapeutics of Parkinson's disease are reviewed, highlighting the current pipeline of emerging therapeutic approaches.</div></front></TEI><affiliations><list><country><li>Autriche</li><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Houston</li></settlement><orgName><li>Baylor College of Medicine</li></orgName></list><tree><noCountry><name sortKey="Mahlknecht, Philipp" sort="Mahlknecht, Philipp" uniqKey="Mahlknecht P" first="Philipp" last="Mahlknecht">Philipp Mahlknecht</name></noCountry><country name="Autriche"><noRegion><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name></noRegion></country><country name="États-Unis"><region name="Texas"><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000372 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000372 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:22772874
|texte= Emerging therapies for Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:22772874" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a JankovicV1
| This area was generated with Dilib version V0.6.19. |  |